Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G Sets Four-Point Turnaround Plan

This article was originally published in The Tan Sheet

Executive Summary

P&G CEO A.G. Lafley’s plan to return the firm to solid fiscal performance focuses on productivity and innovation. While health care product sales grew, the firm reported slight overall growth for its fourth quarter and flat growth for its fiscal 2013.

You may also be interested in...



Lafley Back At P&G Helm As McDonald’s Tenure Ends At Four Years

Procter & Gamble turns to its former leader, previously replaced by Bob McDonald in 2009, after facing investor and analyst pressure to shake up management. Lafley’s return as CEO “provides us with new hope,” one market analyst says.

IFRA Implements New Methodology With 49th Amendment To Fragrance Safety Standards

The International Fragrance Association has given its ingredient safety standards a major overhaul based on a new methodology that accounts for aggregate exposure and an updated Quantitative Risk Assessment model for dermal sensitization.

NIH Study Links Hair Dyes, Straighteners To Breast Cancer Risk; Causation Piece Remains Lacking

Analyzing data from around 47,000 women enrolled in its Sister Study, the National Institute of Environmental Health Sciences found that regular users of permanent hair dye were 9% more likely to develop breast cancer compared with less frequent users. The increased probability reached 60% for African American women who dye their hair every five to eight weeks. Industry and NGO EWG respond.

Topics

Related Companies

UsernamePublicRestriction

Register

PS106545

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel